Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-01 Sale | 2024-04-02 6:07 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 92,500 | $20.5 | $1,896,250 | 897,341 (Indirect Direct) | View |
| 2024-02-13 Sale | 2024-02-15 9:16 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 2,750 | $17.29 | $47,548 | 989,841 (Indirect Direct) | View |
| 2024-01-05 Sale | 2024-01-09 7:34 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 3,208 | $19.43 | $62,331 | 992,591 (Indirect Direct) | View |
| 2023-08-21 Sale | 2023-08-23 4:31 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 1,419 | $22.6 | $32,069 | 995,799 (Indirect Direct) | View |
| 2023-02-13 Sale | 2023-02-15 7:02 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 2,119 | $30.1 | $63,782 | 993,002 (Indirect Direct) | View |
| 2023-02-08 Sale | 2023-02-10 6:10 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 1,377 | $30.88 | $42,522 | 995,121 (Indirect Direct) | View |
| 2023-01-05 Sale | 2023-01-09 9:42 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 2,970 | $28.44 | $84,467 | 996,498 (Indirect Direct) | View |
| 2022-08-19 Sale | 2022-08-23 4:47 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 2,253 | $33.22 | $74,845 | 999,468 (Indirect Direct) | View |
| 2022-02-11 Sale | 2022-02-15 6:56 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer | 2,560 | $34.69 | $88,806 | 970,221 (Indirect Direct) | View |
| 2022-02-09 Sale | 2022-02-11 5:20 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer | 1,296 | $37.09 | $48,073 | 972,781 (Indirect Direct) | View |
| 2022-01-05 Sale | 2022-01-07 6:06 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer | 2,225 | $44.75 | $99,569 | 974,077 (Indirect Direct) | View |
| 2021-08-19 Sale | 2021-08-23 8:24 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer | 2,285 | $49.57 | $113,263 | 945,302 (Indirect Direct) | View |
| 2021-03-15 Sale | 2021-03-16 7:16 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer | 50,000 | $61.89 | $3,094,563 | 947,587 (Indirect Direct) | View |
| 2021-02-16 Sale | 2021-02-18 6:12 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer | 50,000 | $65.09 | $3,254,710 | 997,587 (Indirect Direct) | View |
| 2021-02-11 Sale | 2021-02-16 7:42 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer | 3,035 | $70.34 | $213,480 | 1,047,587 (Indirect Direct) | View |
| 2021-02-09 Sale | 2021-02-11 7:11 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer | 1,448 | $74.68 | $108,135 | 971,479 (Indirect Direct) | View |
| 2021-01-15 Sale | 2021-01-20 6:46 pm | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer | 50,000 | $71.45 | $3,572,556 | 960,177 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-31 Exercise | 2024-04-01 5:25 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 154 | $0 | 7,405 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-01 5:08 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 154 | $0 | 7,405 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-01 5:38 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 155 | $0 | 7,405 (Direct) | View |
| 2023-12-31 Exercise | 2024-01-02 6:06 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 154 | $0 | 7,405 (Direct) | View |
| 2023-11-30 Exercise | 2023-12-04 6:22 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 154 | $0 | 7,405 (Direct) | View |
| 2023-10-31 Exercise | 2023-11-01 8:07 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 154 | $0 | 7,405 (Direct) | View |
| 2023-09-30 Exercise | 2023-10-02 5:14 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 155 | $0 | 7,405 (Direct) | View |
| 2023-08-31 Exercise | 2023-09-05 4:46 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 154 | $0 | 7,405 (Direct) | View |
| 2023-07-31 Exercise | 2023-08-01 6:08 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 154 | $0 | 7,405 (Direct) | View |
| 2023-06-30 Exercise | 2023-07-05 4:59 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 1,851 | $0 | 7,405 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 4:48 pm | N/A 2033-06-15 | Gritstone bio Inc. | GRTS | Krognes Steve E. Director | 51,800 | $0 | 51,800 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 6:10 pm | N/A 2033-06-14 | Guardant Health Inc. | GH | Krognes Steve E. Director | 14,395 | $0 | 14,395 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 6:07 pm | N/A 2033-06-01 | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 16,865 | $0 | 1,009,867 (Direct) | View |
| 2022-08-09 Option Award | 2022-08-11 4:12 pm | N/A N/A | Guardant Health Inc. | GH | Krognes Steve E. Director | 19,284 | $0 | 19,284 (Direct) | View |
| 2022-07-19 Exercise | 2022-07-21 7:36 pm | 2022-07-19 2022-08-01 | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 62,500 | $0 | 1,001,721 (Direct) | View |
| 2022-07-19 Exercise | 2022-07-21 7:36 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. Director | 62,500 | $0.68 | 1,001,721 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 5:34 pm | N/A 2032-06-16 | Gritstone bio Inc. | GRTS | Krognes Steve E. Director | 19,000 | $0 | 19,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 7:03 pm | N/A 2032-01-02 | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer | 124,000 | $0 | 1,069,302 (Direct) | View |
| 2021-06-18 Option Award | 2021-11-19 5:25 pm | N/A 2031-06-17 | Gritstone bio Inc. | GRTS | Krognes Steve E. Director | 19,000 | $0 | 19,000 (Direct) | View |
| 2021-02-07 Exercise | 2021-02-11 7:11 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer | 4,250 | $0 | 971,479 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 6:55 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer | 120,000 | $0 | 120,000 (Direct) | View |
| 2020-08-20 Exercise | 2020-08-24 8:37 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer | 5,643 | $0 | 1,010,177 (Direct) | View |
| 2020-08-21 Tax Withholding | 2020-08-24 8:37 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer | 1,954 | $32.87 | 1,010,177 (Indirect) | View |
| 2020-08-18 Option Award | 2020-08-20 6:17 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Krognes Steve E. CFO and Treasurer | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-06-18 Option Award | 2020-06-22 5:36 pm | N/A 2030-06-18 | Gritstone Oncology Inc. | GRTS | Krognes Steve E. Director | 12,500 | $0 | 12,500 (Direct) | View |